Partner Content Partner Content Hear From AstraZeneca at SMi’s HPAPI 2018 Hear From AstraZeneca at SMi’s HPAPI 2018
Partner Content Partner Content Ipsen presents on oral peptides innovations, advances and de... Ipsen presents on oral peptides innovations & delivery
Partner Content Partner Content PLIVA explores impact of EU Guidelines on evaluation of modi... PLIVA explores EU Guidelines for modified release drugs
Events Partner Content 10th annual Adaptive Designs in Clinical Trials Adaptive Designs in Clinical Trials 2018
Partner Content Partner Content Agenda released for SMi Group’s Controlled Release Delivery ... Agenda released for Controlled Release Delivery 2018
Events Partner Content Controlled Release Delivery 2018 15th annual Controlled Release Delivery in London
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.